The Signature, Derived From a Liquid Biopsy Test, has the Potential to Avoid the Complications of Repeated Needle Biopsies ROTTERDAM, Netherlands–(BUSINESS WIRE)–Exosome Diagnostics, a developer of revolutionary biofluid-based molecular diagnostics, in collaboration with Brigham and Women’s Hospital, in Boston, Mass., ...
Read More »Liquid Biopsy Provides A More Comprehensive View of Genetic Changes Occurring in Cancer Tumors
from Oncology Nurse Advisor by Kathy Boltz, PhD Analyzing tumor DNA fragments in the bloodstream, known as circulating tumor DNA (ctDNA), may offer a more complete view of a patient’s cancer from a molecular perspective. These findings were published in ...
Read More »RNA-seq for blood-based pan-cancer diagnostics
from Nature Reviews Genetics by Liesbet Lieben A systemic, minimally invasive diagnostic test to determine whether an individual has cancer could greatly improve cancer prognosis by facilitating early diagnosis and improving monitoring. However, the use of blood-based ‘liquid biopsies’ is ...
Read More »